Great Lakes Retirement Inc. Has $1.47 Million Stock Position in Sanofi $SNY

Great Lakes Retirement Inc. raised its stake in shares of Sanofi (NASDAQ:SNY) by 6.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 30,322 shares of the company’s stock after purchasing an additional 1,956 shares during the quarter. Great Lakes Retirement Inc.’s holdings in Sanofi were worth $1,465,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently added to or reduced their stakes in the company. Mirae Asset Global Investments Co. Ltd. boosted its holdings in Sanofi by 124.0% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 24,131 shares of the company’s stock valued at $1,344,000 after purchasing an additional 13,358 shares in the last quarter. Axxcess Wealth Management LLC raised its stake in shares of Sanofi by 130.5% in the first quarter. Axxcess Wealth Management LLC now owns 10,234 shares of the company’s stock valued at $568,000 after acquiring an additional 5,794 shares during the last quarter. Ballentine Partners LLC raised its stake in shares of Sanofi by 68.7% in the first quarter. Ballentine Partners LLC now owns 26,063 shares of the company’s stock valued at $1,445,000 after acquiring an additional 10,617 shares during the last quarter. Voya Investment Management LLC raised its stake in shares of Sanofi by 11.6% in the first quarter. Voya Investment Management LLC now owns 206,635 shares of the company’s stock valued at $11,460,000 after acquiring an additional 21,540 shares during the last quarter. Finally, U.S. Capital Wealth Advisors LLC bought a new position in shares of Sanofi in the first quarter valued at approximately $332,000. 14.04% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

SNY has been the subject of a number of research analyst reports. Weiss Ratings reiterated a “hold (c)” rating on shares of Sanofi in a research note on Wednesday, October 8th. Wall Street Zen upgraded shares of Sanofi from a “hold” rating to a “buy” rating in a research note on Saturday, August 2nd. Deutsche Bank Aktiengesellschaft upgraded shares of Sanofi from a “hold” rating to a “buy” rating in a research note on Tuesday, September 2nd. Morgan Stanley upgraded shares of Sanofi from an “equal weight” rating to an “overweight” rating and lifted their target price for the company from $56.00 to $58.00 in a research note on Monday, September 8th. Finally, Jefferies Financial Group reiterated a “buy” rating on shares of Sanofi in a research note on Monday, October 27th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, Sanofi has an average rating of “Buy” and a consensus target price of $62.67.

Sanofi Stock Performance

SNY stock opened at $50.58 on Friday. The company has a debt-to-equity ratio of 0.16, a current ratio of 1.06 and a quick ratio of 0.94. The company has a 50 day moving average price of $48.69 and a 200 day moving average price of $49.55. Sanofi has a fifty-two week low of $44.62 and a fifty-two week high of $60.12. The stock has a market capitalization of $124.20 billion, a PE ratio of 11.85, a price-to-earnings-growth ratio of 1.38 and a beta of 0.51.

Sanofi (NASDAQ:SNY) last issued its earnings results on Friday, October 24th. The company reported $1.70 EPS for the quarter, beating the consensus estimate of $1.60 by $0.10. The company had revenue of $14.53 billion during the quarter, compared to analysts’ expectations of $12.62 billion. Sanofi had a net margin of 21.96% and a return on equity of 12.70%. The business’s revenue for the quarter was down 7.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.25 EPS. Analysts forecast that Sanofi will post 4.36 EPS for the current year.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.